Gen-Next Probiotics and Microbiome Congress

Registration

Opening note by MarketsandMarkets

Opening remarks by Chairman

TACKLING THE MECHANISM OF ACTION THROUGH MICROBIOTA AND PROBIOTIC FUNCTIONALITY

Small Molecule Mining of Human Surrogate Microbiome for Therapeutics

Ross Youngs, CEO & Founder, Biosortia Pharmaceuticals

Clinical trials on the microbiome, what we learned so far

Dr. Sabine Hazan, Founder/ CEO, ProgenaBiome, Ventura Clinical Trials, Malibu Specialty Center

Morning refreshment and Networking

The Unique Microbiome of the Human Infant

David Kyle, Executive Chairman and CSO, Evolve BioSystems, Inc

Powerful therapeutic effects - using Live Probiotic Technology in wound care

Maya Ivanjesku, Chief Scientific Officer, M2B Pharma

The effect of skin care products on the skin microbiome and metabolome

Chris Callewaert, Postdoctoral Research Fellow, Knight lab at University of California

Advancing Microbiome Research: From challenging samples to insight with confidence”

Sujash Chatterjee, PhD., Genomics Application Specialist, QIAGEN

Evaluating neuroprotective effects of novel therapeutics using an alzheimer’s disease model that dramatically impacts gut microbiota dysbiosis

Mo Kagalwala, Head of Business Development, Amylgen

Keynote presentation

Will Polese, Vice President - Japan, Geo Head - West Region USA, MarketsandMarkets™

Lunch and Poster Presentations | One-to-One Networking Meetings

ADDRESSING THE CHALLENGES IN MICROBIOME THERAPEUTICS

IP Protection as a Value Driver

Michael Bush, President & CEO, Prenexus Health

Skin Microbiome as a Therapeutic Source: From Probiotic to Electrobiotic

Eric Huang, Professor, University of California San Diego

Small intestine microbiome aspiration (simba) capsule: a new autonomous and minimally-invasive device for gut microbiome sampling, mapping and monitoring

Gang (Joseph) Wang, CEO, Nimble Science

Getting past current limitations of sequencing for microbiome research

Tuval Ben-Yehezkel, Founder & CEO, Loop Genomics

World-leading gut microbiome bioinformatics and bioprospecting capabilities of microba

Dr. Kylie Ellis, Manager of Research Partnerships, Microba

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

EMERGING MICROBIAL TRENDS & THE FUTURE OF PROBIOTICS IN THE CONSUMER MARKETPLACE

Back to Health: What can we learn about health from the microbiome of hunter-gatherers

Larry Weiss, Chief Executive Officer and Founder, Symbiome

Next-Generation Probiotics: Modulating Gut Microbiota for Health Wellness

Andrea Azcarate-Peril, Associate Professor of Medicine, Director, UNC Microbiome Core, School of Medicine, University of North Carolina at Chapel Hill

Otc topical use of live probiotics for skin therapeutics

Ellie Hang Trinh, Founder and Co-Owner, Skin Probiotics by Skin Recovery, LLC

Closing remarks

Drink Reception & Networking

End of Day 1

Registration

Opening note by MarketsandMarkets

Opening remarks by Chairman

Bharath Prithiviraj, Microbiology Lead scientist, Ahara Biosciences, Inc

Viome’s systems biology platform for developing personalized nutrition algorithms based on molecular data

Momchilo Vuyisich, Founder and Chief Science Officer, Viome, Inc

Pathogenesis inspired probiotic bioengineering to prevent enteric disease

Arun Bhunia, Professor of Food Microbiology, Chair,, Purdue Institute of Inflammation, Immunology and Infectious Disease

Microbial systems: formulating microbial guilds for targeted metabolic outputs

Martha Carlin, CEO, The BioCollective, LLC

Longitudinal microbiome-metabolome interaction analysis for clinical research

Alexey Melnik, Metabolomics Lead, Clarity Genomics

Morning Refreshments and Poster Presentations | One-to-One Networking Meetings

RAISING THE BAR: APPLYING NEW MICROBIOME SCIENCE & ANALYZING THE CONCEPT OF PROBIOTICS

Direct-Fed Microbials: Understanding Today’s Foundation Shaping Tomorrow’s Success

A. Bruce Johnson, PhD, Corporate Vice President, Business Development, Phibro Animal Health Corporation

Gut-Brain axis mechanism of action and Clinical results on Hafnia alvei HA4597, a new probiotic strain for the regulation of appetite and weight management

Gregory Lambert, CEO and VP Research and Development, TargEDys

Leveraging flow cytometry for accurate probiotic enumeration to support R&D and manufacturing decisions

Jennie Starr, Director of Marketing , BioForm Solutions

Probiotic formulations- Compositional quality and ingredient interactions

Shikha Snigdha, Director Of Innovation, MeriCal LLC

The Microbiome of Idiopathic Neurodegenerative Disease (MIND) Consortium

Christopher Ellis, Sr. Staff Scientist , OAK Ridge National Laboratory

Gut Microbiome-based Disease Development and Drug Discovery

Yu-Jui Yvonne Wan, Professor and Vice Chair for Research, Department of Pathology and Laboratory Medicine, University of California, Davis

Lunch and Poster Presentations | One-to-One Networking Meetings

May the Fiber Be with You: Assessing Gut Microbiome Response to a High Fiber Diet Intervention

How the functionally targeted probiotics can be applied into consumer nutrition products for optimizing wellness? The presentation will include:

Peter Leighton, CEO, ProSperity Bioscience

Species-level 16S Metagenome Analysis Via Simultaneous, Weighted Analysis of ALL Hypervariable Domains

Seth Crosby, Director, Research Collaborations, Washington University School of Medicine

Closing remarks

End of Conference